Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 11 2022
Historique:
entrez: 22 11 2022
pubmed: 23 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

There is growing evidence that the impact of COVID-19 crisis may be stronger for individuals with multimorbidity, frailty and lower socioeconomic status. Existing reviews focus on few, mainly short-term effects of COVID-19 illness and patients with single chronic disease. Information is also largely missing for population representative samples.Applying population-based approach, the systematic reviews will have two objectives: (1) to evaluate the aetiological roles of frailty, multimorbidity and socioeconomic status on SARS-CoV-2 infection probability, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation and COVID-19 related mortality among general population and (2) to investigate the prognostic roles of frailty, multimorbidity and socioeconomic characteristics on the risk of hospitalisation, ICU admission, mechanical ventilation, COVID-19 mortality, functioning, quality of life, disability, mental health and work absence. For this ongoing work, four databases were searched: PubMed, Embase, WHO COVID-19 Global literature on coronavirus disease and PsycINFO, for the period between January 2020 and April 7 2021. Peer-reviewed published literature in English and all types of population-based studies will be considered. Studies using standard tools to assess multimorbidity such as disease count, comorbidity indices or disease combinations will be retained, as well as studies with standard scales and scores for frailty or measurement of a socioeconomic gradient. Initial search included 10 139 articles, 411 for full-text reading. Results will be summarised by risk factor, objective and outcome. The feasibility of meta-analysis will be determined by the findings and will aim to better understand uncertainties of the results. Quality of studies will be assessed using standardised scales. The study will be based on published evidence, and it is exempt from the ethical approval. This work is part of the Population Health Information Research Infrastructure (PHIRI) project. Dissemination of the results will imply conference presentation, submission for scientific publication and PHIRI project report. CRD42021249444.

Identifiants

pubmed: 36414309
pii: bmjopen-2022-063573
doi: 10.1136/bmjopen-2022-063573
pmc: PMC9684277
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e063573

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Eur J Public Health. 2019 Feb 1;29(1):182-189
pubmed: 29878097
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
J Am Geriatr Soc. 2021 Sep;69(9):2419-2429
pubmed: 34048599
J Health Monit. 2020 Oct 09;5(Suppl 7):e1-e12
pubmed: 35146300
J Comorb. 2020 Oct 13;10:2235042X20961676
pubmed: 33117721
J Med Internet Res. 2020 Nov 26;22(11):e23449
pubmed: 33197230
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
PLoS One. 2020 Aug 20;15(8):e0238091
pubmed: 32817712
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
EClinicalMedicine. 2021 May 23;36:100896
pubmed: 34036252
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):2103-2109
pubmed: 33161221
J Nutr Health Aging. 2021;25(5):702-709
pubmed: 33949641
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Biometrics. 1994 Dec;50(4):1088-101
pubmed: 7786990
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMC Geriatr. 2021 Mar 17;21(1):186
pubmed: 33731018
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104324
pubmed: 33352430
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Aging Clin Exp Res. 2020 Sep;32(9):1897-1905
pubmed: 32705587
Biometrics. 2000 Jun;56(2):455-63
pubmed: 10877304
Epidemiology. 2009 Jul;20(4):488-95
pubmed: 19525685
PLoS One. 2021 Sep 7;16(9):e0244346
pubmed: 34492018
Geriatr Nurs. 2021 Sep-Oct;42(5):983-992
pubmed: 34256158
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Age Ageing. 2021 May 5;50(3):608-616
pubmed: 33951151
Environ Int. 2016 Jul-Aug;92-93:611-6
pubmed: 26827182
Hypertension. 2020 Aug;76(2):366-372
pubmed: 32564693
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
PLoS Med. 2015 Oct 27;12(10):e1001895
pubmed: 26506244
J Comorb. 2013 Oct 8;3:4-9
pubmed: 29090140
PLoS One. 2022 Jul 21;17(7):e0271786
pubmed: 35862418
BMC Med. 2020 May 29;18(1):160
pubmed: 32466757
BMJ. 2021 Mar 29;372:n160
pubmed: 33781993
J Clin Med. 2020 Jul 04;9(7):
pubmed: 32635468
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):535-545
pubmed: 32408118
PLoS One. 2016 Jan 25;11(1):e0147601
pubmed: 26808317
BMC Public Health. 2013 Feb 19;13:154
pubmed: 23421987
BMJ Open. 2015 Feb 03;5(2):e006413
pubmed: 25649210
PLoS Med. 2021 Apr 26;18(4):e1003584
pubmed: 33901171
Int J Equity Health. 2021 Nov 24;20(1):248
pubmed: 34819081
Ageing Res Rev. 2019 Aug;53:100903
pubmed: 31048032

Auteurs

Tatjana T Makovski (TT)

Department of non-communicable diseases and injuries, Santé publique France, Saint-Maurice, Île-de-France, France tatjana.makovski@santepubliquefrance.fr.

Jinane Ghattas (J)

Institut de recherche santé et société (IRSS), Université catholique de Louvain, Woluwe-Saint-Lambert, Brussels, Belgium.

Stephanie Monnier Besnard (S)

Department of non-communicable diseases and injuries, Santé publique France, Saint-Maurice, Île-de-France, France.

Monika Ambrozova (M)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Barbora Vasinova (B)

Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.

Rodrigo Feteira-Santos (R)

Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Área Disciplinar Autónoma de Bioestatística, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Peter Bezzegh (P)

Directorate for Project Management, National Directorate General for Hospitals, Budapest, Hungary.

Felipe Ponce Bollmann (F)

Universidad Nacional de Educación a Distancia, Madrid, Spain.

James Cottam (J)

Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium.
Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Romana Haneef (R)

Department of non-communicable diseases and injuries, Santé publique France, Saint-Maurice, Île-de-France, France.

Brecht Devleesschauwer (B)

Department of Epidemiology and Public Health, Sciensano, Brussel, Belgium.
Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

Niko Speybroeck (N)

Institut de recherche santé et société (IRSS), Université catholique de Louvain, Woluwe-Saint-Lambert, Brussels, Belgium.

Paulo Nogueira (P)

Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Área Disciplinar Autónoma de Bioestatística, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Maria João Forjaz (MJ)

National Center of Epidemiology, Instituto de Salud Carlos III, REDISSEC and RICAPPS, Madrid, Spain.

Joel Coste (J)

Department of non-communicable diseases and injuries, Santé publique France, Saint-Maurice, Île-de-France, France.

Laure Carcaillon-Bentata (L)

Department of non-communicable diseases and injuries, Santé publique France, Saint-Maurice, Île-de-France, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH